Entrepreneurs at the Series A funding level tend to report that their part of the funding lifecycle remains very challenging, as has been for the last decade. They also report that many A Round investors are angels, often knowledgeable of the sector such as medtech executives, and physicians and surgeons active in the startup’s area.
The is article No. 2 in a three-part series about medtech investing trends:
- Part 1 looks at what is driving the underlying trends.
- Part 2, the present article, looks at these trends from the entrepreneur’s perspective.
- Part 3, coming soon, gives advice from the trenches, to guide entrepreneurs looking to tune up their business plans to be in the best position when Series A comes around.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.